The current stock price for Royalty Pharma plc (RPRX) is $36.46. The stock experienced a significant increase during the last trading session, reaching $55.0 after opening at $36.46. It dipped to a low of $32.19 before ultimately closing at $35.86.
Royalty Pharma plc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $38.00 on 08/05/25, with the lowest value being $24.05 on 12/19/24.
52-week price history of RPRX Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Royalty Pharma plc’s current trading price is -4.05% away from its 52-week high, while its distance from the 52-week low is 51.60%. The stock’s price range for this period has remained between $24.05 and $38.00. The Healthcare sector company’s shares managed to surpass a trading volume of around 5.23 million for the day, which was noticeably higher compared to the shares’ average daily volume of 4.41 million over the last three months.
Financial Performance and Market Capitalization
Royalty Pharma plc (RPRX) has experienced a quarterly rise of 11.09% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 20.87B and boasts a workforce of 99 employees.
Analysts’ Ratings For Royalty Pharma plc
As of right now, 3 analysts are rating Royalty Pharma plc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 34.10, with a change in price of +2.96. Similarly, Royalty Pharma plc recorded 4,477,357 in trading volume during the last 100 days, posting a change of +8.84%.
RPRX Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RPRX stands at 1.26. Similarly, the long-term debt-to-equity ratio is also 1.11.
RPRX Stock Stochastic Average
As of today, the raw stochastic average of Royalty Pharma plc over the last 50 days is at 70.10%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 44.20%. Further, the company’s Stochastic %K and %D values for the last 20 days were 33.70% and 47.34%, respectively.
RPRX Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant gain of 38.84% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 13.05%. Over the past 30 days, the price of RPRX has leaped by -0.14%. And in the last five days, it has fallen by -1.78%.
